speb/financial-data huggingface dataset:
Financial ratios for CEPS.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -14019178.082191782
Buffett classification: The Gruesome
Stock price: 0.0030136986301369864
Shares outstanding: 21000000
Book value: 7215068.493150681
P/B ratio: 0.008771596734383904
Market cap (USD): 63287.67123287672
Debt to equity: 2.318397569774066
Current ratio: 0.8815017598748534
Quick ratio: 0.6793116933906922
Buyback yield (%): 0
Retained earnings: 3819178.082191781
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIPLA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.8818409600422
Shares outstanding: 807845316
Market cap (USD): 10406534881.027035
Buyback yield (%): 0
Retained earnings: 2066341817.2227352
Capitalized R&D asset: 35036265.33034419
Rule of 40 score: 0
Financial ratios for CIPLA.NS — annual report dated 2023-03-31
Total revenue: 2737293544.4579782
Gross profit: 1645864799.0255787
Operating income: 489387332.5213155
Net income: 345053593.17904997
Capital expenditures: 98904993.90986602
Operating cash flow: 394354445.7978076
Depreciation & amortization: 124140073.0816078
Net tangible assets: 2301313032.8867235
Owner earnings: 370288672.35079175
Return on net tangible assets (%): 16.090321788440427
Capex to operating income (%): 20.20996199478828
Buffett classification: The Great
Stock price: 10.575395858708893
P/E ratio: 24.759295883844416
Shares outstanding: 807845316
Book value: 2888372716.1997566
P/B ratio: 2.957819107412221
Market cap (USD): 8543284009.303777
Debt to equity: 0.03386757101638979
Current ratio: 3.3808347701514974
Quick ratio: 2.3716834942373968
Effective tax rate (%): 29.785927420852577
Interest coverage ratio: 42.49016497461929
COGS to revenue (%): 39.87255030218242
R&D to revenue (%): 1.7148885916456862
SG&A to revenue (%): 11.669198573588606
Free cash flow (dilution-adjusted): 245520097.44214377
Buyback yield (%): 0
Retained earnings: 2199394640.682095
Inventory turnover: 1.7377584879461176
Receivables turnover: 5.539359132363816
Capitalized R&D asset: 70415832.48509431
ROCI (R&D-adjusted, %): 16.76143250172625
FCF margin (%): 8.969447136542314
Rule of 40 score: 8.969447136542314
Financial ratios for CIPLA.NS — annual report dated 2024-03-31
Total revenue: 3051520566.0151095
Gross profit: 1901217172.3228204
Operating income: 643801415.0377743
Net income: 498107686.77299434
Capital expenditures: 127602830.07554862
Operating cash flow: 495732102.17052406
Depreciation & amortization: 126036695.0473678
Net tangible assets: 2637413358.915937
Owner earnings: 496541551.74481344
Return on net tangible assets (%): 18.826838427363857
Capex to operating income (%): 19.82021584529473
Buffett classification: The Great
Stock price: 17.454654510556622
P/E ratio: 28.308458719244015
Shares outstanding: 807845316
Book value: 3214094016.0690727
P/B ratio: 4.387133922733518
Market cap (USD): 14100660888.75144
Debt to equity: 0.020871692871477967
Current ratio: 3.7061117814925164
Quick ratio: 2.707602506400395
Effective tax rate (%): 27.12411652256265
Interest coverage ratio: 75.47673274286518
COGS to revenue (%): 37.69607213214481
R&D to revenue (%): 1.69161889020275
SG&A to revenue (%): 10.940387784158451
Free cash flow (dilution-adjusted): 328390694.3278571
Buyback yield (%): 0
Retained earnings: 2570905384.3386497
Inventory turnover: 1.8313233230557757
Receivables turnover: 5.333985234747393
Capitalized R&D asset: 94632894.15036874
ROCI (R&D-adjusted, %): 19.205708123766865
Rosenberg metric: 5.43979601123629
FCF margin (%): 10.761542884067557
Revenue growth (%): 11.479478413753851
Rule of 40 score: 22.24102129782141
Financial ratios for CIPLA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 2777289775.4419494
Buffett classification: The Gruesome
Stock price: 19.367056856187293
Shares outstanding: 807845316
Book value: 3398922599.1399903
P/B ratio: 4.603101632833682
Market cap (USD): 15645586165.976591
Debt to equity: 0.01621392912090268
Current ratio: 3.8397759771210676
Quick ratio: 2.818132653809489
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIPLA.NS — quarterly report dated 2024-12-31
Total revenue: 811469868.2830166
Gross profit: 547560321.7158177
Operating income: 199221354.47021797
Net income: 183540039.63165867
Capital expenditures: 0
Depreciation & amortization: 32614523.83727707
Owner earnings: 216154563.46893573
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 17.470334537824918
P/E ratio: 19.22377258071117
Shares outstanding: 807845316
Market cap (USD): 14113327925.334885
Effective tax rate (%): 17.34626244069955
Interest coverage ratio: 116.74316939890711
COGS to revenue (%): 32.52240864169157
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIPLA.NS — quarterly report dated 2025-03-31
Total revenue: 771302314.7065699
Gross profit: 515396305.8218377
Operating income: 143659106.8505962
Net income: 142838438.15758708
Capital expenditures: 0
Depreciation & amortization: 36091886.836567685
Net tangible assets: 3063719897.124152
Owner earnings: 178930324.99415475
Return on net tangible assets (%): 5.840296469729912
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.497724355233984
P/E ratio: 23.32637054308021
Shares outstanding: 807845316
Book value: 3657850128.594809
P/B ratio: 3.643563534997755
Market cap (USD): 13327609345.034895
Debt to equity: 0.014004490360107705
Current ratio: 4.246661171853916
Quick ratio: 3.217822522410813
Effective tax rate (%): 18.565445722262847
Interest coverage ratio: 87.65049928673322
COGS to revenue (%): 33.17843133688608
Buyback yield (%): 0
Retained earnings: 2997928454.524199
Inventory turnover: 0.3879789653161672
Receivables turnover: 1.1981977237272468
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8518538022034234
Revenue growth (%): -4.949974749085496
Rule of 40 score: -4.949974749085496
Financial ratios for CIPLA.NS — annual report dated 2025-03-31
Total revenue: 3173415945.756371
Gross profit: 2032108954.8749123
Operating income: 718286181.9032031
Net income: 616380640.6359597
Capital expenditures: 132956511.57353283
Operating cash flow: 585104044.8912789
Depreciation & amortization: 116372457.32990412
Net tangible assets: 3063719897.124152
Owner earnings: 599796586.392331
Return on net tangible assets (%): 19.57739631992295
Capex to operating income (%): 18.510242146277314
Buffett classification: The Great
Stock price: 16.497724355233984
P/E ratio: 21.62236849503245
Shares outstanding: 807845316
Book value: 3657850128.594809
P/B ratio: 3.643563534997755
Market cap (USD): 13327609345.034895
Debt to equity: 0.014004490360107705
Current ratio: 4.246661171853916
Quick ratio: 3.217822522410813
Effective tax rate (%): 22.427834817272434
Interest coverage ratio: 139.57791912766925
COGS to revenue (%): 35.96462015663796
R&D to revenue (%): 1.3857228112313686
SG&A to revenue (%): 10.885895952905464
Free cash flow (dilution-adjusted): 398578442.83376193
Buyback yield (%): 0
Retained earnings: 2997928454.524199
Inventory turnover: 1.7303349278904525
Receivables turnover: 4.929817647560916
Capitalized R&D asset: 94050920.99434116
ROCI (R&D-adjusted, %): 18.69278955934092
Rosenberg metric: 2.535674800682744
FCF margin (%): 12.559918070833366
Revenue growth (%): 3.994578345589886
Rule of 40 score: 16.55449641642325
Financial ratios for CIPLA.NS — quarterly report dated 2025-06-30
Total revenue: 800028083.3138311
Gross profit: 546025040.9548327
Operating income: 178495202.4338872
Net income: 151839457.0559326
Capital expenditures: 0
Depreciation & amortization: 29571729.464076765
Owner earnings: 181411186.52000937
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 17.45728996021531
P/E ratio: 29.490299080856303
Shares outstanding: 807845316
Market cap (USD): 14102789924.413763
Effective tax rate (%): 26.99993785064946
Interest coverage ratio: 108.57081850533808
COGS to revenue (%): 31.749265764131845
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 3.7243202904414283
Rule of 40 score: 3.7243202904414283
Financial ratios for CIPLA.NS — quarterly report dated 2025-12-31
Total revenue: 775645538.598641
Gross profit: 482442909.65801495
Operating income: 108801381.30778657
Net income: 75281274.3678289
Capital expenditures: 0
Depreciation & amortization: 31007017.93472207
Owner earnings: 106288292.30255097
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.678734543834242
P/E ratio: 24.343011433027453
Shares outstanding: 807845316
Market cap (USD): 13473837578.04389
Effective tax rate (%): 24.47066990628254
Interest coverage ratio: 69.61582323592302
COGS to revenue (%): 37.80111073292001
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.0477111021145724
Rule of 40 score: -3.0477111021145724
Financial ratios for CIS.DE — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 47.6904761904762
Shares outstanding: 3941434665
Market cap (USD): 187968896047.50003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIS.DE — annual report dated 2022-07-31
Total revenue: 51557000000
Gross profit: 32248000000
Operating income: 13975000000
Net income: 11812000000
Capital expenditures: 477000000
Operating cash flow: 13226000000
Depreciation & amortization: 1957000000
Net tangible assets: -1100000000
Owner earnings: 13292000000
Return on net tangible assets (%): -1208.3636363636365
Capex to operating income (%): 3.413237924865832
Buffett classification: The Great
Stock price: 39.80612244897959
P/E ratio: 13.282528860450633
Shares outstanding: 3941434665
Book value: 39773000000
P/B ratio: 3.9447170417027344
Market cap (USD): 156893230899.64285
Debt to equity: 0.23923264526186105
Current ratio: 1.4320202808112326
Quick ratio: 1.3318642745709828
Effective tax rate (%): 18.408510050424812
Interest coverage ratio: 38.81944444444444
COGS to revenue (%): 37.45175242935004
R&D to revenue (%): 13.138856023430378
SG&A to revenue (%): 21.69637488604845
Free cash flow (dilution-adjusted): 10863000000
Buyback yield (%): 5.341849327687647
Retained earnings: -1319000000
Inventory turnover: 7.519080996884735
Receivables turnover: 4.897596656217346
Capitalized R&D asset: 6774000000
ROCI (R&D-adjusted, %): 24.61004045996593
FCF margin (%): 21.069883817910274
Rule of 40 score: 21.069883817910274
Financial ratios for CIS.DE — annual report dated 2023-07-31
Total revenue: 56998000000
Gross profit: 35753000000
Operating income: 15562000000
Net income: 12613000000
Capital expenditures: 849000000
Operating cash flow: 19886000000
Depreciation & amortization: 1726000000
Net tangible assets: 4000000000
Owner earnings: 13490000000
Return on net tangible assets (%): 337.25
Capex to operating income (%): 5.455596966970826
Buffett classification: The Great
Stock price: 47.49450549450549
P/E ratio: 14.841551601766186
Shares outstanding: 3941434665
Book value: 44353000000
P/B ratio: 4.220604927582731
Market cap (USD): 187196490353.0769
Debt to equity: 0.18918675174170857
Current ratio: 1.3845220224216679
Quick ratio: 1.2681337634545977
Effective tax rate (%): 17.658963311137224
Interest coverage ratio: 36.44496487119438
COGS to revenue (%): 37.273237657461664
R&D to revenue (%): 13.247833257307274
SG&A to revenue (%): 21.681462507456402
Free cash flow (dilution-adjusted): 16684000000
Buyback yield (%): 2.6122284615362314
Retained earnings: 1639000000
Inventory turnover: 5.8301317233809
Receivables turnover: 6.191396915055399
Capitalized R&D asset: 12089580000
ROCI (R&D-adjusted, %): 22.192215225520005
Rosenberg metric: 0.5174195453203425
FCF margin (%): 29.271202498333277
Revenue growth (%): 10.553368116841554
Rule of 40 score: 39.824570615174835
Financial ratios for CIS.DE — annual report dated 2024-07-31
Total revenue: 53803000000
Gross profit: 34828000000
Operating income: 12970000000
Net income: 10320000000
Capital expenditures: 670000000
Operating cash flow: 10880000000
Depreciation & amortization: 2507000000
Net tangible assets: -24422000000
Owner earnings: 12157000000
Return on net tangible assets (%): -49.778887887969866
Capex to operating income (%): 5.165767154973015
Buffett classification: The Great
Stock price: 46.21739130434783
P/E ratio: 17.65143684232811
Shares outstanding: 3941434665
Book value: 45457000000
P/B ratio: 4.007365822927736
Market cap (USD): 182162828212.82608
Debt to equity: 0.6813692060628727
Current ratio: 0.9082889808791642
Quick ratio: 0.8251774098166765
Effective tax rate (%): 15.644923982344286
Interest coverage ratio: 12.892644135188867
COGS to revenue (%): 35.26755013660948
R&D to revenue (%): 14.837462595022583
SG&A to revenue (%): 24.491199375499505
Free cash flow (dilution-adjusted): 7136000000
Buyback yield (%): 3.721395888781381
Retained earnings: 1087000000
Inventory turnover: 5.62555588496887
Receivables turnover: 5.367953706475107
Capitalized R&D asset: 15277590000
ROCI (R&D-adjusted, %): 13.638850857445503
Rosenberg metric: -0.1225003310819759
FCF margin (%): 13.263200936750739
Revenue growth (%): -5.605459840696165
Rule of 40 score: 7.657741096054574
Financial ratios for CIS.DE — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52.71739130434782
Shares outstanding: 3941434665
Market cap (USD): 207782153535.32608
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIS.DE — quarterly report dated 2025-01-31
Capital expenditures: 0
Depreciation & amortization: 761000000
Buffett classification: The Gruesome
Stock price: 58.989583333333336
Shares outstanding: 3941434665
Market cap (USD): 232503588623.90625
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIS.DE — quarterly report dated 2025-04-30
Total revenue: 14149000000
Gross profit: 9278000000
Operating income: 3236000000
Net income: 2491000000
Capital expenditures: 261000000
Operating cash flow: 4057000000
Depreciation & amortization: 626000000
Net tangible assets: -22732000000
Owner earnings: 2856000000
Return on net tangible assets (%): -12.563786732359668
Capex to operating income (%): 8.065512978986403
Buffett classification: The Great
Stock price: 55.73863636363636
P/E ratio: 22.04839357120292
Shares outstanding: 3941434665
Book value: 45935000000
P/B ratio: 4.782631839413647
Market cap (USD): 219690193543.46588
Debt to equity: 0.6374006748666594
Current ratio: 0.9513262791708943
Quick ratio: 0.8692274242643862
Effective tax rate (%): 15.473362741771293
Interest coverage ratio: 8.029776674937965
COGS to revenue (%): 34.42646123400947
R&D to revenue (%): 16.502933069474874
SG&A to revenue (%): 24.475227931302566
Free cash flow (dilution-adjusted): 2851000000
Buyback yield (%): 1.099275284457424
Retained earnings: 152000000
Inventory turnover: 1.7199858757062148
Receivables turnover: 1.718154219793564
Capitalized R&D asset: 2335000000
ROCI (R&D-adjusted, %): 5.469706999003295
FCF margin (%): 20.14983391052371
Rule of 40 score: 20.14983391052371
Financial ratios for CIS.DE — quarterly report dated 2025-07-31
Total revenue: 14673000000
Gross profit: 9280000000
Operating income: 3122000000
Net income: 2550000000
Capital expenditures: 217000000
Operating cash flow: 4234000000
Depreciation & amortization: 635000000
Net tangible assets: -21468000000
Owner earnings: 2968000000
Return on net tangible assets (%): -13.825228246692753
Capex to operating income (%): 6.950672645739911
Buffett classification: The Great
Stock price: 67.40229885057471
P/E ratio: 52.70020971837826
Shares outstanding: 3941434665
Book value: 46843000000
P/B ratio: 5.67132244284834
Market cap (USD): 265661757190.34482
Debt to equity: 0.599726746792477
Current ratio: 0.9977754962354551
Quick ratio: 0.9075404973762263
Effective tax rate (%): 14.971657219073025
Interest coverage ratio: 8.483695652173912
COGS to revenue (%): 36.75458324814285
R&D to revenue (%): 16.22026852041164
SG&A to revenue (%): 24.016901792407825
Free cash flow (dilution-adjusted): 3069000000
Buyback yield (%): 0.5887185331230813
Retained earnings: 50000000
Inventory turnover: 1.70448798988622
Receivables turnover: 1.5030731407498463
Capitalized R&D asset: 3944450000
ROCI (R&D-adjusted, %): 4.310925551072549
Rosenberg metric: 0.0008565310492505353
FCF margin (%): 20.91596810468207
Revenue growth (%): 3.7034419393596725
Rule of 40 score: 24.619410044041743
Financial ratios for CIS.DE — annual report dated 2025-07-31
Total revenue: 56654000000
Gross profit: 36790000000
Operating income: 12504000000
Net income: 10180000000
Capital expenditures: 905000000
Operating cash flow: 14193000000
Depreciation & amortization: 2811000000
Net tangible assets: -21468000000
Owner earnings: 12086000000
Return on net tangible assets (%): -56.2977454816471
Capex to operating income (%): 7.237683941138835
Buffett classification: The Great
Stock price: 67.40229885057471
P/E ratio: 26.096439802587902
Shares outstanding: 3941434665
Book value: 46843000000
P/B ratio: 5.67132244284834
Market cap (USD): 265661757190.34482
Debt to equity: 0.599726746792477
Current ratio: 0.9977754962354551
Quick ratio: 0.9075404973762263
Effective tax rate (%): 8.288288288288289
Interest coverage ratio: 7.849340866290019
COGS to revenue (%): 35.061955025240934
R&D to revenue (%): 16.415434038196775
SG&A to revenue (%): 24.637271860768877
Free cash flow (dilution-adjusted): 9647000000
Buyback yield (%): 2.7184944029506988
Retained earnings: 50000000
Inventory turnover: 6.278128950695322
Receivables turnover: 5.803523868059824
Capitalized R&D asset: 17140440000
ROCI (R&D-adjusted, %): 12.959980622309027
Rosenberg metric: 0.24577226606538896
FCF margin (%): 17.027923888869275
Revenue growth (%): 5.298961024478189
Rule of 40 score: 22.326884913347463
Financial ratios for CIS.DE — quarterly report dated 2025-10-31
Total revenue: 14883000000
Gross profit: 9745000000
Operating income: 3510000000
Net income: 2860000000
Capital expenditures: 323000000
Operating cash flow: 3212000000
Depreciation & amortization: 606000000
Net tangible assets: -20959000000
Owner earnings: 3143000000
Return on net tangible assets (%): -14.995944462999189
Capex to operating income (%): 9.202279202279202
Buffett classification: The Great
Stock price: 72.31395348837209
P/E ratio: 36.07400620709625
Shares outstanding: 3941434665
Book value: 46873000000
P/B ratio: 6.0807015348338584
Market cap (USD): 285020723042.26746
Debt to equity: 0.5992575683229151
Current ratio: 0.9273645313249274
Quick ratio: 0.8315985444698316
Effective tax rate (%): 15.659097611324095
Interest coverage ratio: 10.028571428571428
COGS to revenue (%): 34.522609688906805
R&D to revenue (%): 16.125781092521667
SG&A to revenue (%): 24.215547940603376
Free cash flow (dilution-adjusted): 1834000000
Buyback yield (%): 0.7985384275593456
Retained earnings: -364000000
Inventory turnover: 1.51340206185567
Receivables turnover: 1.881066734074823
Capitalized R&D asset: 4765150000
ROCI (R&D-adjusted, %): 3.9133864175076396
Rosenberg metric: 0.1953781512605042
FCF margin (%): 12.322784384868642
Revenue growth (%): 1.431200163565733
Rule of 40 score: 13.753984548434374
Financial ratios for CIS.DE — quarterly report dated 2026-01-31
Total revenue: 15349000000
Gross profit: 9972000000
Operating income: 3817000000
Net income: 3175000000
Capital expenditures: 283000000
Operating cash flow: 1822000000
Depreciation & amortization: 659000000
Net tangible assets: -19818000000
Owner earnings: 3551000000
Return on net tangible assets (%): -17.918054294076093
Capex to operating income (%): 7.414199633219806
Buffett classification: The Great
Stock price: 77.9047619047619
P/E ratio: 27.72269132719393
Shares outstanding: 3941434665
Book value: 47723000000
P/B ratio: 6.434141381304611
Market cap (USD): 307056529140
Debt to equity: 0.6304297718081429
Current ratio: 0.9550100581743054
Quick ratio: 0.8484477790463764
Effective tax rate (%): 12.918266593527154
Interest coverage ratio: 10.316216216216215
COGS to revenue (%): 35.031598149716594
R&D to revenue (%): 15.343019089191479
SG&A to revenue (%): 23.252329141963646
Free cash flow (dilution-adjusted): 605000000
Buyback yield (%): 0.35140109315442647
Retained earnings: 66000000
Inventory turnover: 1.3716836734693878
Receivables turnover: 1.6072251308900523
Capitalized R&D asset: 4748400000
ROCI (R&D-adjusted, %): 4.153646603177662
Rosenberg metric: 0.09458333333333334
FCF margin (%): 3.9416248615544984
Revenue growth (%): 3.1310891621312904
Rule of 40 score: 7.072714023685789
Financial ratios for CPEDU.NS — quarterly report dated 2025-09-30
Total revenue: 1287226.606538895
Gross profit: 1231961.6685456594
Operating income: 576482.5253664036
Net income: 571567.0800450958
Capital expenditures: 0
Depreciation & amortization: 17294.25028184893
Net tangible assets: 7812683.201803833
Owner earnings: 588861.3303269447
Return on net tangible assets (%): 7.537248280987323
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.9436302142051862
P/E ratio: 21.123471137140726
Shares outstanding: 18192939
Book value: 7852164.599774521
P/B ratio: 6.820193877129078
Market cap (USD): 53553284.925591886
Debt to equity: 0
Current ratio: 6.4509082746235675
Quick ratio: 6.382563199336926
Effective tax rate (%): 24.99741105111325
COGS to revenue (%): 4.293334033999843
Buyback yield (%): 0
Inventory turnover: 0.6192521475492673
Receivables turnover: 5.146353556296764
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.292314362154237
Revenue growth (%): -24.25680561650419
Rule of 40 score: -24.25680561650419
Financial ratios for CPEDU.NS — quarterly report dated 2025-12-31
Total revenue: 1629809.513200401
Gross profit: 1596145.7056923248
Operating income: 611373.5100813189
Net income: 570346.4409045338
Capital expenditures: 0
Depreciation & amortization: 16519.995544168432
Owner earnings: 586866.4364487022
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.871226467639523
P/E ratio: 21.456953241153254
Shares outstanding: 18192939
Market cap (USD): 52236047.98095132
Effective tax rate (%): 29.124154375069317
COGS to revenue (%): 2.0655056456242997
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 26.614032441626236
Rule of 40 score: 26.614032441626236
Financial ratios for CRBP — annual report dated 2021-12-31
Capital expenditures: 54172
Buffett classification: The Gruesome
Stock price: 18.48
Shares outstanding: 18527795
Market cap (USD): 342393651.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRBP — annual report dated 2022-12-31
Total revenue: 0
Operating income: -34835445
Net income: -42346903
Capital expenditures: 5349
Operating cash flow: -37544435
Depreciation & amortization: 1487853
Net tangible assets: 32990017
Owner earnings: -40864399
Return on net tangible assets (%): -123.86898436578558
Buffett classification: The Gruesome
Stock price: 3.33
Shares outstanding: 18527795
Book value: 32990017
P/B ratio: 1.870188710421095
Market cap (USD): 61697557.35
Debt to equity: 0.7605220391368698
Current ratio: 4.761186486832451
Quick ratio: 4.761186486832451
Free cash flow (dilution-adjusted): -43277521
Buyback yield (%): 0
Retained earnings: -392080667
Capitalized R&D asset: 16136826
ROCI (R&D-adjusted, %): -34.49071083101409
Rule of 40 score: 0
Financial ratios for CRBP — annual report dated 2023-12-31
Total revenue: 0
Operating income: -45078000
Net income: -44604000
Capital expenditures: 0
Operating cash flow: -36100000
Depreciation & amortization: 641000
Net tangible assets: -6905000
Owner earnings: -43963000
Buffett classification: The Gruesome
Stock price: 6.04
Shares outstanding: 18527795
Book value: -6905000
Market cap (USD): 111907881.8
Debt to equity: -3.0246198406951486
Current ratio: 0.7382579795572835
Quick ratio: 0.7382579795572835
Interest coverage ratio: -11.684292379471229
Free cash flow (dilution-adjusted): -39570000
Buyback yield (%): 0
Retained earnings: -436684000
Capitalized R&D asset: 41979673.42
ROCI (R&D-adjusted, %): -77.37245950339324
Rule of 40 score: 0
Financial ratios for CRBP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.63
Shares outstanding: 18527795
Market cap (USD): 382228410.84999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRBP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.8
Shares outstanding: 18527795
Market cap (USD): 218627981
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRBP — annual report dated 2024-12-31
Total revenue: 0
Operating income: -48721000
Net income: -40209000
Capital expenditures: 0
Operating cash flow: -41794000
Depreciation & amortization: 588000
Net tangible assets: 142428000
Owner earnings: -39621000
Return on net tangible assets (%): -27.81826607127812
Buffett classification: The Gruesome
Stock price: 11.8
Shares outstanding: 18527795
Book value: 142428000
P/B ratio: 1.53500702811245
Market cap (USD): 218627981
Debt to equity: 0.02274131490998961
Current ratio: 12.944322220341851
Quick ratio: 12.944322220341851
Interest coverage ratio: -26.026175213675213
Free cash flow (dilution-adjusted): -47939000
Buyback yield (%): 0
Retained earnings: -476893000
Capitalized R&D asset: 58429712.58
ROCI (R&D-adjusted, %): -21.239463999124617
Rule of 40 score: 0
Financial ratios for CRBP — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -19775000
Net income: -16978000
Capital expenditures: 0
Operating cash flow: -16421000
Depreciation & amortization: 81000
Net tangible assets: 127106000
Owner earnings: -16897000
Return on net tangible assets (%): -13.293628939625195
Buffett classification: The Gruesome
Stock price: 5.31
Shares outstanding: 18527795
Book value: 127106000
P/B ratio: 0.7740200419335043
Market cap (USD): 98382591.44999999
Debt to equity: 0.022461567510581718
Current ratio: 11.820998278829604
Quick ratio: 11.820998278829604
Free cash flow (dilution-adjusted): -18135000
Buyback yield (%): 0
Retained earnings: -493871000
Capitalized R&D asset: 15642000
ROCI (R&D-adjusted, %): -6.493091495140775
Rule of 40 score: 0
Financial ratios for CRBP — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -19152000
Net income: -17662000
Capital expenditures: 0
Operating cash flow: -16599000
Depreciation & amortization: 53000
Net tangible assets: 110991000
Owner earnings: -17609000
Return on net tangible assets (%): -15.865250335612796
Buffett classification: The Gruesome
Stock price: 6.9
Shares outstanding: 18527795
Book value: 110991000
P/B ratio: 1.1518211882044491
Market cap (USD): 127841785.5
Debt to equity: 0.022127920281824653
Current ratio: 9.212105302632565
Quick ratio: 9.212105302632565
Free cash flow (dilution-adjusted): -18162000
Buyback yield (%): 0
Retained earnings: -511533000
Capitalized R&D asset: 25667140
ROCI (R&D-adjusted, %): -10.363427782573325
Rule of 40 score: 0
Financial ratios for CRBP — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -24417000
Net income: -23342000
Capital expenditures: 0
Operating cash flow: -15550000
Depreciation & amortization: 50000
Net tangible assets: 92147000
Owner earnings: -23292000
Return on net tangible assets (%): -25.277003049475294
Buffett classification: The Gruesome
Stock price: 12.65
Shares outstanding: 18527795
Book value: 92147000
P/B ratio: 2.5435077294974335
Market cap (USD): 234376606.75
Debt to equity: 0.022236209534765104
Current ratio: 6.305451348182884
Quick ratio: 6.305451348182884
Free cash flow (dilution-adjusted): -17132000
Buyback yield (%): 0
Retained earnings: -534875000
Capitalized R&D asset: 36197150
ROCI (R&D-adjusted, %): -16.157388928638934
Rule of 40 score: 0
Financial ratios for CRBP — annual report dated 2025-12-31
Total revenue: 0
Operating income: -85310000
Net income: -78537000
Capital expenditures: 7000
Operating cash flow: -64491000
Depreciation & amortization: 233000
Net tangible assets: 147503000
Owner earnings: -78311000
Return on net tangible assets (%): -53.09112357036806
Buffett classification: The Gruesome
Stock price: 8.14
Shares outstanding: 18527795
Book value: 147503000
P/B ratio: 1.0224622638183631
Market cap (USD): 150816251.3
Debt to equity: 0.011070961268584367
Current ratio: 8.068528900057993
Quick ratio: 8.068528900057993
Free cash flow (dilution-adjusted): -70786000
Buyback yield (%): 0
Retained earnings: -555430000
Capitalized R&D asset: 101969180
ROCI (R&D-adjusted, %): -23.934532499776125
Rule of 40 score: 0
Financial ratios for CRBP — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -21966000
Net income: -20555000
Capital expenditures: 0
Operating cash flow: -15921000
Depreciation & amortization: 49000
Net tangible assets: 147503000
Owner earnings: -20506000
Return on net tangible assets (%): -13.902090126980468
Buffett classification: The Gruesome
Stock price: 8.14
Shares outstanding: 18527795
Book value: 147503000
P/B ratio: 1.0224622638183631
Market cap (USD): 150816251.3
Debt to equity: 0.011070961268584367
Current ratio: 8.068528900057993
Quick ratio: 8.068528900057993
Free cash flow (dilution-adjusted): -17357000
Buyback yield (%): 0
Retained earnings: -555430000
Capitalized R&D asset: 37393910
ROCI (R&D-adjusted, %): -11.742218947845046
Rule of 40 score: 0
Financial ratios for CSPI — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.29
Shares outstanding: 10071847
Market cap (USD): 43208223.63
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSPI — annual report dated 2022-09-30
Total revenue: 54361000
Gross profit: 18827000
Operating income: -40000
Net income: 1889000
Capital expenditures: 232000
Operating cash flow: 2675000
Depreciation & amortization: 935000
Net tangible assets: 38953000
Owner earnings: 2592000
Return on net tangible assets (%): 6.654172977691064
Buffett classification: The Gruesome
Stock price: 3.47
P/E ratio: 18.501487077818954
Shares outstanding: 10071847
Book value: 38963000
P/B ratio: 0.8969871182917126
Market cap (USD): 34949309.09
Debt to equity: 0.13286964556117342
Current ratio: 1.9699489762109867
Quick ratio: 1.825094427142005
Effective tax rate (%): 2.5786487880350695
Interest coverage ratio: -0.1111111111111111
COGS to revenue (%): 65.36671510825775
R&D to revenue (%): 5.673184819999632
SG&A to revenue (%): 29.033682235426134
Free cash flow (dilution-adjusted): 1462000
Buyback yield (%): 0.497863919289284
Retained earnings: 26769000
Inventory turnover: 8.127630375114364
Receivables turnover: 2.2593931837073984
Capitalized R&D asset: 3084000
ROCI (R&D-adjusted, %): 4.203152364273205
FCF margin (%): 2.68942808263277
Rule of 40 score: 2.68942808263277
Financial ratios for CSPI — annual report dated 2023-09-30
Total revenue: 64647000
Gross profit: 21920000
Operating income: 1870000
Net income: 5204000
Capital expenditures: 226000
Operating cash flow: 3907000
Depreciation & amortization: 931000
Net tangible assets: 46102000
Owner earnings: 5909000
Return on net tangible assets (%): 12.8172313565572
Capex to operating income (%): 12.085561497326204
Buffett classification: The Great
Stock price: 8.54
P/E ratio: 16.52835768255188
Shares outstanding: 10071847
Book value: 46148000
P/B ratio: 1.8638635126115974
Market cap (USD): 86013573.38
Debt to equity: 0.06388142498049754
Current ratio: 3.2162973369946997
Quick ratio: 3.053962577431509
Effective tax rate (%): -9.904963041182683
Interest coverage ratio: 7.137404580152672
COGS to revenue (%): 66.09278079415904
R&D to revenue (%): 4.857147276749115
SG&A to revenue (%): 26.157439633703035
Free cash flow (dilution-adjusted): 2504000
Buyback yield (%): 0.006975643220277056
Retained earnings: 31311000
Inventory turnover: 16.80841856805665
Receivables turnover: 3.2121136837921096
Capitalized R&D asset: 5206280
ROCI (R&D-adjusted, %): 5.293535754870462
Rosenberg metric: 1.0029182879377432
FCF margin (%): 3.873342923878911
Revenue growth (%): 18.92165339121797
Rule of 40 score: 22.79499631509688
Financial ratios for CSPI — annual report dated 2024-09-30
Total revenue: 55219000
Gross profit: 18855000
Operating income: -1872000
Net income: -326000
Capital expenditures: 196000
Operating cash flow: 4213000
Depreciation & amortization: 794000
Net tangible assets: 47220000
Owner earnings: 272000
Buffett classification: The Gruesome
Stock price: 12.77
Shares outstanding: 10071847
Book value: 47270000
P/B ratio: 2.720911491220647
Market cap (USD): 128617486.19
Debt to equity: 0.09875185106833087
Current ratio: 2.9359276308746387
Quick ratio: 2.8131891660421795
Interest coverage ratio: -7.965957446808511
COGS to revenue (%): 65.85414440681649
R&D to revenue (%): 5.353229866531447
SG&A to revenue (%): 32.18276317934045
Free cash flow (dilution-adjusted): 2428000
Buyback yield (%): 0.08085992276848433
Retained earnings: 29848000
Inventory turnover: 15.85870039249891
Receivables turnover: 2.9250450259561394
Capitalized R&D asset: 6077520
ROCI (R&D-adjusted, %): -3.4769437804936416
Rosenberg metric: -0.9761146496815286
FCF margin (%): 4.39703725167062
Revenue growth (%): -14.583816727767724
Rule of 40 score: -10.186779476097104
Financial ratios for CSPI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.77
Shares outstanding: 10071847
Market cap (USD): 128617486.19
Buyback yield (%): 0.02643497475123526
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSPI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.83
Shares outstanding: 10071847
Market cap (USD): 159437338.01
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSPI — quarterly report dated 2025-03-31
Total revenue: 13147000
Gross profit: 4207000
Operating income: -994000
Net income: -108000
Capital expenditures: 7000
Operating cash flow: 1912000
Depreciation & amortization: 183000
Net tangible assets: 47406000
Owner earnings: 68000
Buffett classification: The Gruesome
Stock price: 15.14
Shares outstanding: 10071847
Book value: 47453000
P/B ratio: 3.2134483295049843
Market cap (USD): 152487763.58
Debt to equity: 0.013782058036372832
Current ratio: 3.343206269092841
Quick ratio: 3.2031478283968653
Interest coverage ratio: -12.909090909090908
COGS to revenue (%): 68.0003042519206
R&D to revenue (%): 5.803605385258995
SG&A to revenue (%): 33.75675058948809
Free cash flow (dilution-adjusted): 1457000
Buyback yield (%): 0
Retained earnings: 29235000
Inventory turnover: 4.238975817923186
Receivables turnover: 0.7807007125890736
Capitalized R&D asset: 763000
ROCI (R&D-adjusted, %): -0.9187221181087954
FCF margin (%): 11.08237620749981
Rule of 40 score: 11.08237620749981
Financial ratios for CSPI — quarterly report dated 2025-06-30
Total revenue: 15448000
Gross profit: 4453000
Operating income: -1223000
Net income: -264000
Capital expenditures: 66000
Operating cash flow: -3283000
Depreciation & amortization: 169000
Net tangible assets: 47439000
Owner earnings: -161000
Return on net tangible assets (%): -0.33938320790910437
Buffett classification: The Gruesome
Stock price: 12.79
Shares outstanding: 10071847
Book value: 47484000
P/B ratio: 2.712891145017269
Market cap (USD): 128818923.13
Debt to equity: 0.02725128464324825
Current ratio: 3.22165820642978
Quick ratio: 2.9918000780944944
Interest coverage ratio: -11.647619047619047
COGS to revenue (%): 71.17426204039357
R&D to revenue (%): 5.120403935784568
SG&A to revenue (%): 31.622216468151215
Free cash flow (dilution-adjusted): -3752000
Buyback yield (%): 0.1948471497054037
Retained earnings: 28423000
Inventory turnover: 3.1129671574178936
Receivables turnover: 0.8883777100465812
Capitalized R&D asset: 1302210
ROCI (R&D-adjusted, %): -1.801965508104008
Rosenberg metric: 0.3224115334207077
FCF margin (%): -24.28793371310202
Revenue growth (%): 17.50209173195406
Rule of 40 score: -6.785841981147961
Financial ratios for CSPI — annual report dated 2025-09-30
Total revenue: 58730000
Gross profit: 18511000
Operating income: -3109000
Net income: -91000
Capital expenditures: 348000
Operating cash flow: 2268000
Depreciation & amortization: 702000
Net tangible assets: 44482000
Owner earnings: 263000
Buffett classification: The Gruesome
Stock price: 11.45
Shares outstanding: 10071847
Book value: 44551000
P/B ratio: 2.588553526295706
Market cap (USD): 115322648.14999999
Debt to equity: 0.05788871181342731
Current ratio: 2.3585628634539963
Quick ratio: 2.2935581300996257
Interest coverage ratio: -8.708683473389355
COGS to revenue (%): 68.48118508428401
R&D to revenue (%): 5.533798739996595
SG&A to revenue (%): 31.27873318576537
Free cash flow (dilution-adjusted): 125000
Buyback yield (%): 0.7535380204499753
Retained earnings: 27700000
Inventory turnover: 27.89112343966713
Receivables turnover: 2.804813983475811
Capitalized R&D asset: 6266720
ROCI (R&D-adjusted, %): -5.383728361309656
Rosenberg metric: -0.11637347767253045
FCF margin (%): 0.21283841307679208
Revenue growth (%): 6.358318694652203
Rule of 40 score: 6.571157107728995
Financial ratios for CSPI — quarterly report dated 2025-09-30
Total revenue: 14465000
Gross profit: 5287000
Operating income: -538000
Net income: -185000
Capital expenditures: 228000
Operating cash flow: 1898000
Depreciation & amortization: 153000
Net tangible assets: 44482000
Owner earnings: -260000
Return on net tangible assets (%): -0.5845060923519626
Buffett classification: The Gruesome
Stock price: 11.45
Shares outstanding: 10071847
Book value: 44551000
P/B ratio: 2.588553526295706
Market cap (USD): 115322648.14999999
Debt to equity: 0.05788871181342731
Current ratio: 2.3585628634539963
Quick ratio: 2.2935581300996257
Interest coverage ratio: -5.489795918367347
COGS to revenue (%): 63.449706187348774
R&D to revenue (%): 6.291047355686138
SG&A to revenue (%): 33.978568959557556
Free cash flow (dilution-adjusted): 1233000
Buyback yield (%): 0.20290897213497608
Retained earnings: 27700000
Inventory turnover: 6.3647711511789185
Receivables turnover: 0.6908161803333492
Capitalized R&D asset: 1691760
ROCI (R&D-adjusted, %): -0.8867529632547466
Rosenberg metric: 1.054361567635904
FCF margin (%): 8.5240235050121
Revenue growth (%): -6.363283272915588
Rule of 40 score: 2.1607402320965114
Financial ratios for CSPI — quarterly report dated 2025-12-31
Total revenue: 12036000
Gross profit: 4735000
Operating income: -112000
Net income: 91000
Capital expenditures: 105000
Operating cash flow: -2916000
Depreciation & amortization: 165000
Net tangible assets: 44743000
Owner earnings: 151000
Return on net tangible assets (%): 0.33748295822810276
Buffett classification: The Gruesome
Stock price: 12.42
P/E ratio: 343.660274010989
Shares outstanding: 10071847
Book value: 44810000
P/B ratio: 2.7916165976344565
Market cap (USD): 125092339.74
Debt to equity: 0.060455255523320685
Current ratio: 2.752912186379928
Quick ratio: 2.62040770609319
Effective tax rate (%): 75.47169811320755
Interest coverage ratio: -0.875
COGS to revenue (%): 60.659687603855104
R&D to revenue (%): 7.128614157527418
SG&A to revenue (%): 33.142239946826194
Free cash flow (dilution-adjusted): -3484000
Buyback yield (%): 0
Retained earnings: 27492000
Inventory turnover: 3.0857988165680474
Receivables turnover: 0.6172307692307692
Capitalized R&D asset: 1728730
ROCI (R&D-adjusted, %): -0.20178502426983522
Rosenberg metric: -0.6065934065934065
FCF margin (%): -28.946493851777998
Revenue growth (%): -16.792257172485307
Rule of 40 score: -45.73875102426331
Financial ratios for DBX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.54
Shares outstanding: 158037382
Market cap (USD): 3878237354.2799997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBX — annual report dated 2022-12-31
Total revenue: 2324900000
Gross profit: 1880700000
Operating income: 356500000
Net income: 553200000
Capital expenditures: 34900000
Operating cash flow: 797300000
Depreciation & amortization: 157100000
Net tangible assets: -801000000
Owner earnings: 675400000
Return on net tangible assets (%): -84.31960049937578
Capex to operating income (%): 9.789621318373072
Buffett classification: The Great
Stock price: 22.38
P/E ratio: 6.393486278308026
Shares outstanding: 158037382
Book value: -309400000
Market cap (USD): 3536876609.16
Debt to equity: -7.416289592760181
Current ratio: 1.2451316339323026
Quick ratio: 1.2451316339323026
Effective tax rate (%): -187.07836014530358
COGS to revenue (%): 19.106198116048002
R&D to revenue (%): 38.362940341520066
SG&A to revenue (%): 27.196868682523977
Free cash flow (dilution-adjusted): 431700000
Buyback yield (%): 22.488768704569136
Retained earnings: -2772100000
Receivables turnover: 43.21375464684015
Capitalized R&D asset: 891900000
ROCI (R&D-adjusted, %): 33.90126537159151
FCF margin (%): 18.568540582390643
Rule of 40 score: 18.568540582390643
Financial ratios for DBX — annual report dated 2023-12-31
Total revenue: 2501600000
Gross profit: 2023100000
Operating income: 383500000
Net income: 453600000
Capital expenditures: 24800000
Operating cash flow: 783700000
Depreciation & amortization: 170000000
Net tangible assets: -626100000
Owner earnings: 598800000
Return on net tangible assets (%): -95.63967417345472
Capex to operating income (%): 6.466753585397653
Buffett classification: The Great
Stock price: 29.48
P/E ratio: 10.27103620229277
Shares outstanding: 158037382
Book value: -165800000
Market cap (USD): 4658942021.36
Debt to equity: -12.247285886610374
Current ratio: 1.2622555139409073
Quick ratio: 1.2622555139409073
Effective tax rate (%): 18.181818181818183
COGS to revenue (%): 19.12775823472977
R&D to revenue (%): 37.43604093380237
SG&A to revenue (%): 28.106012152222576
Free cash flow (dilution-adjusted): 421100000
Buyback yield (%): 11.588467886586768
Retained earnings: -2742300000
Receivables turnover: 36.41339155749636
Capitalized R&D asset: 1534073000
ROCI (R&D-adjusted, %): 21.42695089442643
Rosenberg metric: 0.15965915461374594
FCF margin (%): 16.83322673488967
Revenue growth (%): 7.600326895780464
Rule of 40 score: 24.433553630670133
Financial ratios for DBX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.43
Shares outstanding: 158037382
Market cap (USD): 4018890624.2599998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBX — annual report dated 2024-12-31
Total revenue: 2548200000
Gross profit: 2103100000
Operating income: 486300000
Net income: 452300000
Capital expenditures: 32300000
Operating cash flow: 894100000
Depreciation & amortization: 137300000
Net tangible assets: -1250100000
Owner earnings: 557300000
Return on net tangible assets (%): -44.58043356531478
Capex to operating income (%): 6.641990540818425
Buffett classification: The Great
Stock price: 30.04
P/E ratio: 10.496225857351314
Shares outstanding: 158037382
Book value: -752400000
Market cap (USD): 4747442955.28
Debt to equity: -3.982721956406167
Current ratio: 1.4357449620085894
Quick ratio: 1.4357449620085894
Effective tax rate (%): 11.278932914868577
COGS to revenue (%): 17.467231771446514
R&D to revenue (%): 35.90377521387646
SG&A to revenue (%): 27.544933678675143
Free cash flow (dilution-adjusted): 524900000
Buyback yield (%): 26.15302620159175
Retained earnings: -3146500000
Receivables turnover: 36.19602272727273
Capitalized R&D asset: 1836682000
ROCI (R&D-adjusted, %): 12.319832052755842
Rosenberg metric: 0.08542445274959957
FCF margin (%): 20.598854093085315
Revenue growth (%): 1.8628078030060762
Rule of 40 score: 22.461661896091393
Financial ratios for DBX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.04
Shares outstanding: 158037382
Market cap (USD): 4747442955.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBX — quarterly report dated 2025-03-31
Total revenue: 624700000
Gross profit: 508000000
Operating income: 183800000
Net income: 150300000
Capital expenditures: 6900000
Operating cash flow: 153800000
Depreciation & amortization: 38100000
Net tangible assets: -1567100000
Owner earnings: 181500000
Return on net tangible assets (%): -11.581902877927382
Capex to operating income (%): 3.754080522306855
Buffett classification: The Great
Stock price: 26.71
P/E ratio: 7.021254945475715
Shares outstanding: 158037382
Book value: -1075700000
Market cap (USD): 4221178473.2200003
Debt to equity: -2.797899042483964
Current ratio: 0.726619488296135
Quick ratio: 0.726619488296135
Effective tax rate (%): 11.327433628318584
COGS to revenue (%): 18.680966864094767
R&D to revenue (%): 28.557707699695854
SG&A to revenue (%): 23.339202817352326
Free cash flow (dilution-adjusted): 86200000
Buyback yield (%): 11.823712339252893
Retained earnings: -3335700000
Receivables turnover: 8.724860335195531
Capitalized R&D asset: 178400000
ROCI (R&D-adjusted, %): 23.310489977156642
FCF margin (%): 13.798623339202818
Rule of 40 score: 13.798623339202818
Financial ratios for DBX — quarterly report dated 2025-06-30
Total revenue: 625700000
Gross profit: 502000000
Operating income: 171000000
Net income: 125600000
Capital expenditures: 2000000
Operating cash flow: 260500000
Depreciation & amortization: 39000000
Net tangible assets: -1800300000
Owner earnings: 162600000
Return on net tangible assets (%): -9.03182802866189
Capex to operating income (%): 1.1695906432748537
Buffett classification: The Great
Stock price: 28.6
P/E ratio: 16.382273016310258
Shares outstanding: 158037382
Book value: -1305500000
Market cap (USD): 4519869125.2
Debt to equity: -2.331060896208349
Current ratio: 0.6002048296679603
Quick ratio: 0.6002048296679603
Effective tax rate (%): 15.020297699594046
COGS to revenue (%): 19.769857759309573
R&D to revenue (%): 29.47099248841298
SG&A to revenue (%): 23.429758670289278
Free cash flow (dilution-adjusted): 180800000
Buyback yield (%): 9.071059109081126
Retained earnings: -3487600000
Receivables turnover: 8.25461741424802
Capitalized R&D asset: 303928000
ROCI (R&D-adjusted, %): 19.091386782702347
Rosenberg metric: -0.033632286995515695
FCF margin (%): 28.89563688668691
Revenue growth (%): 0.16007683688170324
Rule of 40 score: 29.055713723568612
Financial ratios for DBX — quarterly report dated 2025-09-30
Total revenue: 634400000
Gross profit: 506100000
Operating income: 174700000
Net income: 123800000
Capital expenditures: 8400000
Operating cash flow: 302100000
Depreciation & amortization: 39600000
Net tangible assets: -2025000000
Owner earnings: 155000000
Return on net tangible assets (%): -7.654320987654321
Capex to operating income (%): 4.80824270177447
Buffett classification: The Great
Stock price: 30.21
P/E ratio: 11.944731824418314
Shares outstanding: 158037382
Book value: -1531200000
Market cap (USD): 4774309310.22
Debt to equity: -2.125587774294671
Current ratio: 0.5688839848675914
Quick ratio: 0.5688839848675914
Effective tax rate (%): 21.246819338422394
COGS to revenue (%): 20.223833543505677
R&D to revenue (%): 28.73581336696091
SG&A to revenue (%): 23.50252206809584
Free cash flow (dilution-adjusted): 215100000
Buyback yield (%): 8.16453176097294
Retained earnings: -3633600000
Receivables turnover: 8.584573748308525
Capitalized R&D asset: 364720000
ROCI (R&D-adjusted, %): 13.94235357745045
Rosenberg metric: 0.022234273318872018
FCF margin (%): 33.906052963430014
Revenue growth (%): 1.390442704171328
Rule of 40 score: 35.29649566760134